n
a
v
Portfolio
Genetics
AmplideX® Fragile X Dx & Carrier Screen Kit
AmplideX® mPCR
FMR1
Kit
AmplideX® PCR/CE
FMR1
Kit
AmplideX®
FMR1
Controls
Xpansion Interpreter®
AmplideX® PCR/CE <em>SMN1/2</em> Plus Kit
AmplideX® PCR/CE <em>CFTR</em> Kit
AmplideX® PCR/CE
C9orf72
Kit
AmplideX® PCR/CE
DMPK
Kit
AmplideX® PCR/CE <em>HTT</em> Kit
AmplideX® TRIO
Oncology
QuantideX® qPCR BCR-ABL IS Kit
QuantideX® qPCR BCR-ABL minor Kit
MolecularDx Controls
Catalog of Armored Products
SARS CoV-2 Controls
Made-To-Order Armored and Nucleic Acid
Molecular Assay Reagents
Custom & Companion Diagnostics
Partnered R&D
CAP-Accredited CLIA Lab
CTA Testing Site
Validated Platforms & Assays
Companion Diagnostics
Enabling Technologies
Assay Chemistries
Bioinformatics
Product Development Process
Resources
Publications
Articles
Whitepapers
Posters
Disease Information
Fragile X Syndrome
Dementia
Chronic Myeloid Leukemia (CML)
Other Resources
Videos
Carrier Screening Guide
Safety Data Sheets
Sales Contacts
Our Culture
Employee Spotlights
Culture & Heritage
Sales Contacts
Contact
About
Leadership Team
Culture and Heritage
News
Upcoming Events
Business Development
Careers
Search
News
Home
News
Press Releases
Year
Select Year
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
March 22, 2024
BIO-TECHNE RECEIVES EUROPEAN IVDR CERTIFICATION FOR DIAGNOSTIC TEST TO MONITOR CHRONIC MYELOID LEUKEMIA
Share
November 1, 2023
Asuragen to Present Novel Clinical Testing Data at AMP 2023 Conference
Share
September 28, 2023
Dr. Jordan Laser Awarded AMP Meritorious Service Award
Share
December 1, 2022
BIO-TECHNE AND OXFORD NANOPORE TECHNOLOGIES PARTNER TO BRING INNOVATIVE REPRODUCTIVE HEALTH AND CARRIER SCREENING SOLUTIONS TO THE MARKET
Share
October 31, 2022
ASURAGEN TO SHOWCASE INNOVATIVE DIAGNOSTIC LAB SOLUTIONS AT AMP 2022 CONFERENCE
Share
November 4, 2021
Asuragen Launches New Kit to Enable Broader Coverage of Gene Variants Linked to Cystic Fibrosis
Share
April 6, 2021
BIO-TECHNE COMPLETES ACQUISITION OF ASURAGEN, INC.
Share
March 3, 2021
BIO-TECHNE TO ACQUIRE ASURAGEN
Share
November 10, 2020
Asuragen to Present at Association for Molecular Pathology (AMP) 2020 Annual Meeting
Share
August 3, 2020
Pacific Biosciences and Asuragen Collaborate to Develop Assays for Carrier Screening and other Applications Based on SMRT Sequencing Technology and AmplideX PCR Chemistry
Share
1
2
3
4
5
6
7
8
Next
About
About
About
Leadership Team
Leadership Team
Culture and Heritage
Culture and Heritage
News
News
Upcoming Events
Upcoming Events
Business Development
Business Development
Back To
Top